Cargando…
Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial
PURPOSE: To evaluate the dynamic remodeling of drusen in subjects with unilateral neovascular age-related macular degeneration (AMD) receiving a three-year course of oral docosahexaenoic acid (DHA) or placebo. SETTING: Institutional setting. METHODS: Three hundred subjects with age-related maculopat...
Autores principales: | Querques, Giuseppe, Merle, Bénédicte M. J., Pumariega, Nicole M., Benlian, Pascale, Delcourt, Cécile, Zourdani, Alain, Leisy, Heather B., Lee, Michele D., Smith, R. Theodore, Souied, Eric H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762680/ https://www.ncbi.nlm.nih.gov/pubmed/26901353 http://dx.doi.org/10.1371/journal.pone.0149219 |
Ejemplares similares
-
CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study
por: Merle, Bénédicte M. J., et al.
Publicado: (2015) -
DHA supplementation for late onset Stargardt disease: NAT-3 study
por: Querques, Giuseppe, et al.
Publicado: (2010) -
Elusive drusen and changing terminology of AMD
por: De Jong, P. T. V. M.
Publicado: (2018) -
Using directional OCT to analyze photoreceptor visibility over AMD-related drusen
por: Marsh-Armstrong, Brennan, et al.
Publicado: (2022) -
Relationship Between Drusen Height and OCT Biomarkers of Atrophy in Non-Neovascular AMD
por: Au, Adrian, et al.
Publicado: (2022)